1. Home
  2. LSTA vs OFAL Comparison

LSTA vs OFAL Comparison

Compare LSTA & OFAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • OFAL
  • Stock Information
  • Founded
  • LSTA 1980
  • OFAL 2013
  • Country
  • LSTA United States
  • OFAL United States
  • Employees
  • LSTA N/A
  • OFAL N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • OFAL Military/Government/Technical
  • Sector
  • LSTA Health Care
  • OFAL Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • OFAL Nasdaq
  • Market Cap
  • LSTA 22.3M
  • OFAL 21.4M
  • IPO Year
  • LSTA N/A
  • OFAL 2025
  • Fundamental
  • Price
  • LSTA $2.17
  • OFAL $1.27
  • Analyst Decision
  • LSTA Strong Buy
  • OFAL
  • Analyst Count
  • LSTA 2
  • OFAL 0
  • Target Price
  • LSTA $23.50
  • OFAL N/A
  • AVG Volume (30 Days)
  • LSTA 25.5K
  • OFAL 351.4K
  • Earning Date
  • LSTA 08-07-2025
  • OFAL 01-01-0001
  • Dividend Yield
  • LSTA N/A
  • OFAL N/A
  • EPS Growth
  • LSTA N/A
  • OFAL N/A
  • EPS
  • LSTA N/A
  • OFAL N/A
  • Revenue
  • LSTA $1,070,000.00
  • OFAL $202,007.00
  • Revenue This Year
  • LSTA N/A
  • OFAL N/A
  • Revenue Next Year
  • LSTA N/A
  • OFAL N/A
  • P/E Ratio
  • LSTA N/A
  • OFAL N/A
  • Revenue Growth
  • LSTA N/A
  • OFAL N/A
  • 52 Week Low
  • LSTA $1.87
  • OFAL $1.09
  • 52 Week High
  • LSTA $4.20
  • OFAL $9.79
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 37.46
  • OFAL N/A
  • Support Level
  • LSTA $2.55
  • OFAL N/A
  • Resistance Level
  • LSTA $2.63
  • OFAL N/A
  • Average True Range (ATR)
  • LSTA 0.17
  • OFAL 0.00
  • MACD
  • LSTA -0.04
  • OFAL 0.00
  • Stochastic Oscillator
  • LSTA 17.86
  • OFAL 0.00

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About OFAL OFA Group Ordinary Shares

OFA Group, through its subsidiary, provides architectural services, including design and fit-out services for commercial and residential buildings in Hong Kong. The design service includes both the consultation with staff and the actual design work and the company provides a specific conceptualized design with layout plans, detailed design drawings, advice relating to, among other things, budgetary consideration, optimal use of space, the materials, fittings, furniture, appliances and other items to be used to produce a preliminary design plan and quotation. Its works include installing protective materials to cover floors or walls, installing or constructing partition walls, windows, window frames, and decorative fittings, furniture or fixtures, installing plumbing systems, etc.

Share on Social Networks: